ATIP Stock Overview
Operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
ATI Physical Therapy, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.06 |
| 52 Week High | US$7.70 |
| 52 Week Low | US$0.41 |
| Beta | -0.16 |
| 1 Month Change | -10.17% |
| 3 Month Change | -29.80% |
| 1 Year Change | -84.64% |
| 3 Year Change | -99.12% |
| 5 Year Change | n/a |
| Change since IPO | -99.79% |
Recent News & Updates
Recent updates
ATI Physical Therapy (NYSE:ATIP) Has Some Difficulty Using Its Capital Effectively
Nov 22
ATI Physical Therapy, Inc. (NYSE:ATIP) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Aug 08Finally, ATI Physical Therapy Within Striking Distance Of Profitability
Jul 22Are Investors Undervaluing ATI Physical Therapy, Inc. (NYSE:ATIP) By 23%?
Nov 08ATI Physical Therapy gets new operations chief
Dec 15ATI Physical Therapy reports Q3 results
Nov 07ATI Physical Therapy nears 52-week low after Jefferies downgrades rating
Oct 27ATI Physical Therapy hits 52-week low amid lackluster Q2 results
Aug 09ATI Physical Therapy: Down But Certainly Not Out
Mar 30ATI Physical Therapy, Inc. (NYSE:ATIP) Just Reported, And Analysts Assigned A US$4.50 Price Target
Mar 01Shareholder Returns
| ATIP | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 3.9% | -1.8% | 1.2% |
| 1Y | -84.6% | -7.0% | 23.7% |
Return vs Industry: ATIP underperformed the US Healthcare industry which returned -7% over the past year.
Return vs Market: ATIP underperformed the US Market which returned 23.7% over the past year.
Price Volatility
| ATIP volatility | |
|---|---|
| ATIP Average Weekly Movement | 68.0% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ATIP's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ATIP's weekly volatility has increased from 34% to 67% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 6,000 | Sharon Vitti | www.atipt.com |
ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services.
ATI Physical Therapy, Inc. Fundamentals Summary
| ATIP fundamental statistics | |
|---|---|
| Market cap | US$4.64m |
| Earnings (TTM) | -US$79.62m |
| Revenue (TTM) | US$728.11m |
0.0x
P/S Ratio-0.1x
P/E RatioIs ATIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ATIP income statement (TTM) | |
|---|---|
| Revenue | US$728.11m |
| Cost of Revenue | US$406.69m |
| Gross Profit | US$321.42m |
| Other Expenses | US$401.05m |
| Earnings | -US$79.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -18.03 |
| Gross Margin | 44.14% |
| Net Profit Margin | -10.94% |
| Debt/Equity Ratio | 707.9% |
How did ATIP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/19 23:19 |
| End of Day Share Price | 2025/02/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ATI Physical Therapy, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Sutherland | Benchmark Company |
| Jason Cassorla | Citigroup Inc |
| Robert Labick | CJS Securities, Inc. |